1.60 USD
▼-0.05-3.03%
盘后 1.58 -1.25%
2026-11-20
市值
$4.74M
市盈率
—
EPS
-2.45
股息率
—
52 周区间
0.97 – 7.91
成交量
32.02K
Beta
2.27
目标价
—
52W 低 0.9752W 高 7.91
价格走势
公司简介
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic...